Caris Life Sciences, Inc.
CAI
Classement en actions
#2204
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Prix de l'action
$31.45
Capitalisation boursière
$8.89B
Changement (1 jour)
-2.78%
Changement (1 an)
4.69%
Pays
US
Échange Caris Life Sciences, Inc. (CAI)
Catégorie
Healthcare
Historique du prix de l'action pour Caris Life Sciences, Inc. (CAI)
Prix de clôture le plus élevé : $29.76 le 2026-10-01
Prix de clôture le plus bas : $26.95 le 2025-06-01
Prix de clôture le plus bas : $26.95 le 2025-06-01
Historique du prix de l'action de Caris Life Sciences, Inc. de 2025 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -17.62% |
| 2025 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $530.66 | 24.44% |
US
|
|
| $230.18 | 757.28% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.66 | 9.40% |
NL
|
|
| $290.41 | 2.03% |
BE
|
